320 related articles for article (PubMed ID: 25271285)
41. Mutants resistant to LpxC inhibitors by rebalancing cellular homeostasis.
Zeng D; Zhao J; Chung HS; Guan Z; Raetz CR; Zhou P
J Biol Chem; 2013 Feb; 288(8):5475-86. PubMed ID: 23316051
[TBL] [Abstract][Full Text] [Related]
42. Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of Leptospira spp.: homology modeling, docking, and molecular dynamics study.
Pradhan D; Priyadarshini V; Munikumar M; Swargam S; Umamaheswari A; Bitla A
J Biomol Struct Dyn; 2014; 32(2):171-85. PubMed ID: 23383626
[TBL] [Abstract][Full Text] [Related]
43. Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa
Moustafa DA; Wu AW; Zamora D; Daly SM; Sturge CR; Pybus C; Geller BL; Goldberg JB; Greenberg DE
mBio; 2021 Jan; 12(1):. PubMed ID: 33436433
[TBL] [Abstract][Full Text] [Related]
44. Mutations Reducing
Jones AK; Caughlan RE; Woods AL; Uehara K; Xie L; Barnes SW; Walker JR; Thompson KV; Ranjitkar S; Lee PS; Dean CR
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658970
[TBL] [Abstract][Full Text] [Related]
45. Exploring the UDP pocket of LpxC through amino acid analogs.
Hale MR; Hill P; Lahiri S; Miller MD; Ross P; Alm R; Gao N; Kutschke A; Johnstone M; Prince B; Thresher J; Yang W
Bioorg Med Chem Lett; 2013 Apr; 23(8):2362-7. PubMed ID: 23499237
[TBL] [Abstract][Full Text] [Related]
46. Design and synthesis of potent Gram-negative specific LpxC inhibitors.
Mansoor UF; Vitharana D; Reddy PA; Daubaras DL; McNicholas P; Orth P; Black T; Siddiqui MA
Bioorg Med Chem Lett; 2011 Feb; 21(4):1155-61. PubMed ID: 21273067
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers.
Howard JJ; Sturge CR; Moustafa DA; Daly SM; Marshall-Batty KR; Felder CF; Zamora D; Yabe-Gill M; Labandeira-Rey M; Bailey SM; Wong M; Goldberg JB; Geller BL; Greenberg DE
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137807
[No Abstract] [Full Text] [Related]
48. Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis.
Lin L; Tan B; Pantapalangkoor P; Ho T; Baquir B; Tomaras A; Montgomery JI; Reilly U; Barbacci EG; Hujer K; Bonomo RA; Fernandez L; Hancock RE; Adams MD; French SW; Buslon VS; Spellberg B
mBio; 2012; 3(5):. PubMed ID: 23033474
[TBL] [Abstract][Full Text] [Related]
49. Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB-78485 inhibitor.
Mochalkin I; Knafels JD; Lightle S
Protein Sci; 2008 Mar; 17(3):450-7. PubMed ID: 18287278
[TBL] [Abstract][Full Text] [Related]
50. Structure of the metal-dependent deacetylase LpxC from Yersinia enterocolitica complexed with the potent inhibitor CHIR-090 .
Cole KE; Gattis SG; Angell HD; Fierke CA; Christianson DW
Biochemistry; 2011 Jan; 50(2):258-65. PubMed ID: 21171638
[TBL] [Abstract][Full Text] [Related]
51. Lipid A Has Significance for Optimal Growth of
Wang T; Yu Y; Liang X; Luo S; He Z; Sun Z; Jiang Y; Omsland A; Zhou P; Song L
Front Cell Infect Microbiol; 2018; 8():192. PubMed ID: 29938202
[TBL] [Abstract][Full Text] [Related]
52. Control of lipopolysaccharide biosynthesis by FtsH-mediated proteolysis of LpxC is conserved in enterobacteria but not in all gram-negative bacteria.
Langklotz S; Schäkermann M; Narberhaus F
J Bacteriol; 2011 Mar; 193(5):1090-7. PubMed ID: 21193611
[TBL] [Abstract][Full Text] [Related]
53. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
54. Essential oils from Moroccan plants as potential chemosensitisers restoring antibiotic activity in resistant Gram-negative bacteria.
Fadli M; Chevalier J; Saad A; Mezrioui NE; Hassani L; Pages JM
Int J Antimicrob Agents; 2011 Oct; 38(4):325-30. PubMed ID: 21752605
[TBL] [Abstract][Full Text] [Related]
55. Small-Molecule Inhibitor of FosA Expands Fosfomycin Activity to Multidrug-Resistant Gram-Negative Pathogens.
Tomich AD; Klontz EH; Deredge D; Barnard JP; McElheny CL; Eshbach ML; Weisz OA; Wintrode P; Doi Y; Sundberg EJ; Sluis-Cremer N
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642934
[TBL] [Abstract][Full Text] [Related]
56. Crystal structure of A. aeolicus LpxC with bound product suggests alternate deacetylation mechanism.
Miller MD; Gao N; Ross PL; Olivier NB
Proteins; 2015 Sep; 83(9):1706-19. PubMed ID: 26177919
[TBL] [Abstract][Full Text] [Related]
57. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.
Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T
mBio; 2020 Apr; 11(2):. PubMed ID: 32291303
[TBL] [Abstract][Full Text] [Related]
58. LpxC inhibition: Potential and opportunities with carbohydrate scaffolds.
Amudala S; Sumit ; Aidhen IS
Carbohydr Res; 2024 Mar; 537():109057. PubMed ID: 38402732
[TBL] [Abstract][Full Text] [Related]
59. Characterization of an Acinetobacter baumannii lptD Deletion Strain: Permeability Defects and Response to Inhibition of Lipopolysaccharide and Fatty Acid Biosynthesis.
Bojkovic J; Richie DL; Six DA; Rath CM; Sawyer WS; Hu Q; Dean CR
J Bacteriol; 2015 Dec; 198(4):731-41. PubMed ID: 26668262
[TBL] [Abstract][Full Text] [Related]
60. Sulfonamide-based non-alkyne LpxC inhibitors as Gram-negative antibacterial agents.
Kawai T; Kazuhiko I; Takaya N; Yamaguchi Y; Kishii R; Kohno Y; Kurasaki H
Bioorg Med Chem Lett; 2017 Feb; 27(4):1045-1049. PubMed ID: 28082037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
